Vivitra 150mg

Brand Name: Vivitra 150mg
Composition: Trastuzumab 150mg
Manufactured By: Zydus
Form: Injection
Packing: 1 vial in 1 box
Storage: 2 to 8 celsius
Share :

Related Products

Vivitra is a brand name for Trastuzumab, a humanized monoclonal antibody used to treat certain types of breast cancer and gastric cancer. Composition: Each 150mg vial of Vivitra 150mg contains trastuzumab, a recombinant humanized monoclonal antibody, and sodium chloride. Mechanism of Action: Trastuzumab is a targeted therapy that works by binding to the human epidermal growth factor receptor 2 (HER2) protein on the surface of breast cancer cells. This binding prevents the HER2 protein from sending growth signals to the cells, ultimately leading to cell death and tumor shrinkage. Use: Vivitra is used to treat:
  1. HER2-positive breast cancer, in combination with chemotherapy (such as doxorubicin, cyclophosphamide, and methotrexate) as adjuvant treatment after surgery.
  2. HER2-positive metastatic breast cancer, in combination with paclitaxel or docetaxel as first-line treatment.
  3. HER2-positive metastatic breast cancer, in combination with chemotherapy (such as docetaxel, carboplatin, and trastuzumab) as first-line treatment.
  4. HER2-positive gastric cancer, in combination with chemotherapy (such as cisplatin and capecitabine) as first-line treatment.
Dosage: The recommended dosage of Vivitra is:
  1. Adjuvant treatment: 8 mg/kg every 3 weeks for 12 cycles.
  2. Metastatic breast cancer: 8 mg/kg every 3 weeks.
  3. Gastric cancer: 8 mg/kg every 3 weeks.
Side Effects: Common side effects of Vivitra include:
  1. Fatigue
  2. Headache
  3. Dizziness
  4. Nausea
  5. Vomiting
  6. Diarrhea
  7. Abdominal pain
  8. Flu-like symptoms
Recommendation: Vivitra should be administered under the guidance of an experienced healthcare provider. Patients should be monitored for signs of cardiac toxicity, including congestive heart failure, and patients with a history of cardiac disease may be at increased risk. Important Note: Vivitra is not recommended for use in patients with a history of allergic reactions to trastuzumab or other ingredients in the product. Patients should be advised to report any changes in their heart rate or blood pressure to their healthcare provider immediately.

Vivitra is a brand name for Trastuzumab, a humanized monoclonal antibody used to treat certain types of breast cancer and gastric cancer.

Composition:

Each 150mg vial of Vivitra 150mg contains trastuzumab, a recombinant humanized monoclonal antibody, and sodium chloride.

Mechanism of Action: Trastuzumab is a targeted therapy that works by binding to the human epidermal growth factor receptor 2 (HER2) protein on the surface of breast cancer cells. This binding prevents the HER2 protein from sending growth signals to the cells, ultimately leading to cell death and tumor shrinkage.

Use: Vivitra is used to treat:

  1. HER2-positive breast cancer, in combination with chemotherapy (such as doxorubicin, cyclophosphamide, and methotrexate) as adjuvant treatment after surgery.
  2. HER2-positive metastatic breast cancer, in combination with paclitaxel or docetaxel as first-line treatment.
  3. HER2-positive metastatic breast cancer, in combination with chemotherapy (such as docetaxel, carboplatin, and trastuzumab) as first-line treatment.
  4. HER2-positive gastric cancer, in combination with chemotherapy (such as cisplatin and capecitabine) as first-line treatment.

Dosage: The recommended dosage of Vivitra is:

  1. Adjuvant treatment: 8 mg/kg every 3 weeks for 12 cycles.
  2. Metastatic breast cancer: 8 mg/kg every 3 weeks.
  3. Gastric cancer: 8 mg/kg every 3 weeks.

Side Effects: Common side effects of Vivitra include:

  1. Fatigue
  2. Headache
  3. Dizziness
  4. Nausea
  5. Vomiting
  6. Diarrhea
  7. Abdominal pain
  8. Flu-like symptoms

Recommendation: Vivitra should be administered under the guidance of an experienced healthcare provider. Patients should be monitored for signs of cardiac toxicity, including congestive heart failure, and patients with a history of cardiac disease may be at increased risk.

Important Note: Vivitra is not recommended for use in patients with a history of allergic reactions to trastuzumab or other ingredients in the product. Patients should be advised to report any changes in their heart rate or blood pressure to their healthcare provider immediately.

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Vivitra is a brand name for Trastuzumab, a humanized monoclonal antibody used to treat certain types of breast cancer and gastric cancer.

Composition:

Each 150mg vial of Vivitra 150mg contains trastuzumab, a recombinant humanized monoclonal antibody, and sodium chloride.

Mechanism of Action: Trastuzumab is a targeted therapy that works by binding to the human epidermal growth factor receptor 2 (HER2) protein on the surface of breast cancer cells. This binding prevents the HER2 protein from sending growth signals to the cells, ultimately leading to cell death and tumor shrinkage.

Use: Vivitra is used to treat:

  1. HER2-positive breast cancer, in combination with chemotherapy (such as doxorubicin, cyclophosphamide, and methotrexate) as adjuvant treatment after surgery.
  2. HER2-positive metastatic breast cancer, in combination with paclitaxel or docetaxel as first-line treatment.
  3. HER2-positive metastatic breast cancer, in combination with chemotherapy (such as docetaxel, carboplatin, and trastuzumab) as first-line treatment.
  4. HER2-positive gastric cancer, in combination with chemotherapy (such as cisplatin and capecitabine) as first-line treatment.

Dosage: The recommended dosage of Vivitra is:

  1. Adjuvant treatment: 8 mg/kg every 3 weeks for 12 cycles.
  2. Metastatic breast cancer: 8 mg/kg every 3 weeks.
  3. Gastric cancer: 8 mg/kg every 3 weeks.

Side Effects: Common side effects of Vivitra include:

  1. Fatigue
  2. Headache
  3. Dizziness
  4. Nausea
  5. Vomiting
  6. Diarrhea
  7. Abdominal pain
  8. Flu-like symptoms

Recommendation: Vivitra should be administered under the guidance of an experienced healthcare provider. Patients should be monitored for signs of cardiac toxicity, including congestive heart failure, and patients with a history of cardiac disease may be at increased risk.

Important Note: Vivitra is not recommended for use in patients with a history of allergic reactions to trastuzumab or other ingredients in the product. Patients should be advised to report any changes in their heart rate or blood pressure to their healthcare provider immediately.

Reviews

There are no reviews yet.

Be the first to review “Vivitra 150mg”

Your email address will not be published. Required fields are marked *

Vivitra is a brand name for Trastuzumab, a humanized monoclonal antibody used to treat certain types of breast cancer and gastric cancer.

Composition:

Each 150mg vial of Vivitra 150mg contains trastuzumab, a recombinant humanized monoclonal antibody, and sodium chloride.

Mechanism of Action: Trastuzumab is a targeted therapy that works by binding to the human epidermal growth factor receptor 2 (HER2) protein on the surface of breast cancer cells. This binding prevents the HER2 protein from sending growth signals to the cells, ultimately leading to cell death and tumor shrinkage.

Use: Vivitra is used to treat:

  1. HER2-positive breast cancer, in combination with chemotherapy (such as doxorubicin, cyclophosphamide, and methotrexate) as adjuvant treatment after surgery.
  2. HER2-positive metastatic breast cancer, in combination with paclitaxel or docetaxel as first-line treatment.
  3. HER2-positive metastatic breast cancer, in combination with chemotherapy (such as docetaxel, carboplatin, and trastuzumab) as first-line treatment.
  4. HER2-positive gastric cancer, in combination with chemotherapy (such as cisplatin and capecitabine) as first-line treatment.

Dosage: The recommended dosage of Vivitra is:

  1. Adjuvant treatment: 8 mg/kg every 3 weeks for 12 cycles.
  2. Metastatic breast cancer: 8 mg/kg every 3 weeks.
  3. Gastric cancer: 8 mg/kg every 3 weeks.

Side Effects: Common side effects of Vivitra include:

  1. Fatigue
  2. Headache
  3. Dizziness
  4. Nausea
  5. Vomiting
  6. Diarrhea
  7. Abdominal pain
  8. Flu-like symptoms

Recommendation: Vivitra should be administered under the guidance of an experienced healthcare provider. Patients should be monitored for signs of cardiac toxicity, including congestive heart failure, and patients with a history of cardiac disease may be at increased risk.

Important Note: Vivitra is not recommended for use in patients with a history of allergic reactions to trastuzumab or other ingredients in the product. Patients should be advised to report any changes in their heart rate or blood pressure to their healthcare provider immediately.

Reviews

There are no reviews yet.

Be the first to review “Vivitra 150mg”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For Vivitra 150mg